EnviroChemie GmbH’s Post

Active Pharmaceutical Ingredient (APIs) 💊 residues after the manufacture of pharmaceutical, medical or cosmetic products are one of the biggest challenges in the treatment of modern industrial wastewater. Such residues resist common treatment methods and pose a significant threat to our aquatic ecosystems. EnviroChemie has been developing solutions for years to reliably purify such wastewater and enable it to be safely discharged into the public sewage system. Our new project in Southern Europe impressively demonstrates the efficiency of our innovative solution and is another milestone in our research. Thanks to the entire project team for their outstanding performance 👏 #envirowatergroup #PharmaceuticalWastewaterTreatment #API

View profile for Dr. Maria Natcheva-Schwarz, graphic

Passionate about water

We are thrilled to announce that #EnviroChemie has successfully completed another crucial milestone in combating residual Active Pharmaceutical Ingredients (APIs) in wastewater from the Pharmaceutical industry! Residual APIs after the production of pharmaceutical products are one of the biggest challenges in modern industrial wastewater treatment. They resist common treatment methods and pose a significant threat to our aquatic ecosystems. Our latest project, a state-of-the-art treatment plant in southeastern Europe for a leading pharmaceutical company, effectively eliminates these harmful substances. This innovative solution allows treated water to be safely discharged into the public sewer system. Thanks to our supportive partners and our team's dedication we are making significant strides in protecting the environment and human health! #Wastewater #EnviroWaterGroup #IndustrialWastewaterTreatment #PharmaceuticalWastewaterTreatment #API #residualActivePharmaceuticalIngredients

  • No alternative text description for this image

Great news! Congrats!

Like
Reply

To view or add a comment, sign in

Explore topics